Print

New era of uveitis: Embracing the modern technology

(included with All-Access Saturday pass)

Saturday, May 3
8am – 5pm MT
Calvin L. Rampton Salt Palace Convention Center

Organizers

Chair: Vishali Gupta, MD; Rupesh Vijay Agrawal, MD, FRCS, MMed; Esen K. Akpek, MD; David S. Chu, MD; Phoebe Lin, MD, PhD; Careen Y. Lowder, MD, PhD; Quan Dong Nguyen, MD, MSc, FARVO and Carlos E Pavesio, FRCOphth, MD

Participating societies

Thank you to the following societies that participated in the development of this session. 

  • American Uveitis Society
  • Foster Ocular Immunology Society
  • International Ocular Inflammation Society
  • International Uveitis Study Group
  • Sociedad Panamericana de Enfermedades Inflamatorias Oculares
Target audience

Basic and clinical researchers and healthcare professionals with knowledge of the diagnosis, treatment and management of uveitis, including ocular imaging techniques. 

From conventional labs to omics: What has changed in the diagnosis of uveitis?

8am - 10:05am
View the agenda

Description
Will highlight the significant advancements in diagnostics, which have evolved from a few basic laboratory tests to cutting-edge 'omics' technologies. Participants will learn from expert presentations and case studies and two debates: Bayesian breakthrough: Can it guide patient treatment in uveitis? and Personalized medicine: Innovation or passing trend? 

Decoding multimodal imaging and artificial intelligence for daily uveitis practice

10:30am - 12:05pm
View the agenda

Description
Will highlight the advances in the field of imaging as well as integration of Artificial intelligence (AI) in our practice and patient management: Combining the old with new is an art that needs to be learnt and mastered. Participants will learn from expert presentations and case studies. Will end with a debate, AI in imaging interpretation: Do I trust it? 

Cutting edge treatments for uveitis

1:05pm - 3:05pm
View the agenda

Description
Will highlight advances in the treatment of uveitis. The experts shall cover a wide spectrum beginning with conventional treatment and elaborating on forthcoming newer therapies, including both local and systemic. Participants will learn from expert presentations, case studies and two debates, Local therapy: Saves patients from systemic side effects and Systemic therapy with biologics: First line or last resort?

Clinical trials in uveitis: What everyone needs to know

3:30pm - 5pm
View the agenda

Description
Explore clinical trials for uveitis classification, standardizing imaging nomenclature and incorporating AI tools in uveitis clinical trials. Will close with a discussion on defining endpoints.

CME credit
CME credit is not available for presentations in this session. 

*Presenters and presentations are subject to change. 


All-Access Saturday pass

NEW: ARVO's All-Access Saturday pass grants you unlimited all-day access to your choice of Saturday sessions for just one registration fee. You have the freedom to move around to various presentations you are interested in within sessions and build your own individual schedule for the day. To sign up, simply add the All-Access Saturday pass to your registration for the 2025 Annual Meeting.

Registration for ARVO's All-Access Saturday is open.

 

Up to
April 25

After
April 25

 

ARVO Member

$235

$320

 

ARVO Member-in-Training

$175

$220

 

Nonmember

$310

$395

 

Nonmember-in-training

$215

$260

 

* Breakfast and lunch included with registration